IGHE and Alzheimer disease: The percentage in all AD patients who showed IgE-reactivity to the M. sympodialis extract, as detectable with ImmunoCapTM or immunoblot analyses, was 47–45%, which is in agreement with previous studies as is the high frequency of head and neck involvement, particularly in the severe AD patients (S2 Table) [15,35–37].